Valuation GC Genome Corporation

Stocks

End-of-day quote Korea S.E. Other stock markets 2026-07-13			5-day change	1st Jan Change
4,450.00 ^KRW	-6.71%		-8.44%	-34.75%

Dec. 09	GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy	CI
25-06-12	GC Genome Shares Decline Nearly 3% After Strong Kosdaq Debut	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2025	2026	2027
Market Cap ¹	161,298	105,246	-
Change	-	-34.75%	-
Enterprise Value (EV) ¹	161.3	45.85	36.45
Change	-	-71.58%	-20.5%
P/E	36.9x	-	-
PBR	-	-	-
PEG	-0x	-	-
Capitalization / Revenue	-	2.7x	2.16x
EV / Revenue	-	1.18x	0.75x
EV / EBITDA	-	-	-
EV / EBIT	-	11.5x	5.21x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ³	-	-	-
Rate of return	-	-	-
EPS ³	185	-	-
Distribution rate	-	-	-
Net sales ¹	-	39	48.8
EBITDA	-	-	-
EBIT ¹	-	4	7
Net income	4.044	-	-
Net Debt ¹	-	-59.4	-68.8
Reference price ³	6,820.00	4,450.00	4,450.00
Nbr of stocks (in thousands)	23,651	23,651	-
Announcement Date	3/16/26	-	-

¹KRW in Million²KRW in Billions³KRW

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GC GENOME CORPORATION	-	1.18x	-	-	70.48M
NATERA, INC.	-163.8x	13.61x	-185.56x	-.--%	39.08B
LABCORP HOLDINGS INC.	19.09x	1.86x	10.69x	1.05%	22.69B
SONIC HEALTHCARE LIMITED	16.77x	1.32x	7.48x	5.19%	7.17B
RADNET, INC.	324.67x	-	-	-	4.98B
DR. LAL PATHLABS LIMITED	48.95x	8.71x	30.94x	1.06%	3.01B
GENEDX HOLDINGS CORP.	-19.09x	-	-	-	1.9B
DIAN DIAGNOSTICS GROUP CO.,LTD.	31.71x	1.13x	9.45x	0.8%	1.82B
NEOGENOMICS, INC.	-31.66x	-	-	-.--%	1.84B
FLEURY S.A.	12.7x	1.32x	5.17x	5.96%	1.71B
Average	26.59x	4.16x	-20.30x	2.01%	8.43B
Weighted average by Cap.	-48.68x	8.13x	-90.56x	0.98%